MedTrace Logo

Of 18F MEL050 Using PET/CT in Metastatic Melanoma

NCT01620749 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2012-06-15

No results posted yet for this study

Summary

The purpose of this study is to investigate the safety and potential effectiveness of the imaging compound 18F MEL050 for finding sites of melanoma.

Conditions

Interventions

RADIATION

18F MEL050

Diagnostic intervention to establish the safety and biodistribution of MEL050 in participants with melanoma.

Sponsors & Collaborators

  • Cooperative Research Centre for Biomedical Imaging Development

    lead OTHER

Principal Investigators

  • Grant McArthur · Peter MacCallum Cancer Centre, Australia

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-03-31
Completion
2012-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01620749 on ClinicalTrials.gov